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Protozoan microtubules are sensitive to disruption by dinitroanilines, compounds that kill intracellular Toxoplasma
gondii parasites without affecting microtubules in vertebrate host cells. We previously isolated a number of resistant
Toxoplasma lines that harbor mutations to the 1-tubulin gene. Some of the mutations are localized in or near the M and
N loops, domains that coordinate lateral interactions between protofilaments. Other resistance mutations map to a
computationally identified binding site beneath the N loop. Allelic replacement of wild-type 1-tubulin with the
individual mutations is sufficient to confer dinitroaniline resistance. Some mutations seem to increase microtubule length,
suggesting that they increase subunit affinity. All mutations are associated with replication defects that decrease parasite
viability. When parasites bearing the N loop mutation Phe52Tyr are grown without dinitroaniline selection, they
spontaneously acquired secondary mutations in the M loop (Ala273Val) or in an -tubulin–specific insert that stabilizes
the M loop (Asp367Val). Parasites with the double mutations have both reduced resistance and diminished incidence of
replication defects, suggesting that the secondary mutations decrease protofilament affinity to increase parasite fitness.
INTRODUCTION
Microtubules are essential components of diverse structures
in eukaryotic cells. These structures include spindles used
for chromosome segregation, flagellar/ciliary axonemes
used for motility, and cytoplasmic microtubule arrays used
as tracks for vesicle transport (Nogales, 2000). Microtubules
are built by the polymerization of --tubulin heterodimers,
and they typically contain 13 protofilaments, a substructure
formed by the longitudinal head-to-tail association of the
heterodimers. The lateral association of protofilaments
forms a microtubule, which consists of a 24-nm-wide cylin-
der with a hollow lumen (Downing and Nogales, 1998a,b; Li
et al., 2002).
Because - and -tubulins are ancestrally related proteins,
they contain many domains that have similar structure and
function, such as the M and N loops, which coordinate
contacts between adjacent protofilaments (Downing, 2000;
Lowe et al., 2001; Li et al., 2002). However, - and -tubulins
also have important differences. For example, although both
- and -tubulins bind to guanosine triphosphate (GTP),
only the -tubulin GTP is hydrolyzed (Davis et al., 1994;
Sage et al., 1995; Anders and Botstein, 2001; Dougherty et al.,
2001). Polymerization-dependent -tubulin GTP hydrolysis
is stimulated by a GTPase-activating domain of -tubulin
from the adjacent dimer within the protofilament. When
GTP is hydrolyzed, dimers undergo a conformation change
that promotes microtubule disassembly (Nicholson et al.,
1999; Nogales et al., 2003; Nogales and Wang, 2006a,b).
Appropriate microtubule disassembly is as essential as as-
sembly to the appropriate function of tubulin. Expression of
mutant -tubulin genes that lack a functional GTPase acti-
vation domain causes a lethal phenotype in budding yeast
associated with extraordinarily long and stable microtubules
(Anders and Botstein, 2001). One of the traits that distin-
guishes -tubulins from -tubulins is a conserved eight-
amino acid insert (Thr, Val, Val, Pro, Gly, Gly, Asp, Leu)
beginning at residue 360 (361 in the Toxoplasma sequence)
(Nogales et al., 1998). The structure of stabilized zinc sheets
demonstrated that Taxol (paclitaxel) occupies the same re-
gion in -tubulin as the insert does in -tubulin (Snyder et
al., 2001). These results indicate that the -tubulin M loop
has greater protofilament stability than the -tubulin M loop
and that by stabilizing the -tubulin loop contacts, microtu-
bules are stabilized.
A diverse array of compounds affect microtubule function
by shifting the normal equilibrium between tubulin dimers
and polymers to destabilize (e.g., colchicines) or stabilize
(e.g., paclitaxel) microtubules (Jordan et al., 1998). Because
the balanced assembly and disassembly of microtubules is a
critically important part of microtubule function, com-
pounds that upset the equilibrium between heterodimer
subunits and polymerized microtubules are toxic. Therapeu-
tic strategies have exploited this feature to inhibit the pro-
liferation of fast-growing cancer cells. Other tubulin-binding
compounds are used as antiparasitic and antifungal agents
and as herbicides. With the exception of the dinitroanilines
and peloruside A, all characterized compounds that alter
tubulin equilibrium bind to and act on -tubulin (Morrissette et
al., 2004; Pineda et al., 2004; Jimenez-Barbero et al., 2006;
Mitra and Sept, 2006). Because -tubulin ligands such as the
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dinitroanilines and peloruside A are only recently identified,
they are likely to be important tools for establishing the role
of -tubulin in the tubulin dimer, much as other tubulin
binding drugs have helped clarify how the -tubulin mono-
mer functions.
The activity of dinitroanilines, informally called the “yel-
low” herbicides, was first reported by scientists from Eli
Lilly in 1960 (Alder et al., 1960). Dinitroanilines (oryzalin,
trifluralin, and ethafluralin) selectively disrupt plant and
protozoan microtubules (Traub-Cseko et al., 2001). These
compounds bind to sensitive (plant and protozoan) but not
resistant (vertebrate and fungal) tubulins. Protozoan para-
sites, including those broadly grouped as kinetoplastids,
apicomplexans and amoeba, are sensitive to dinitroanilines,
which inhibit their replication (Chan and Fong, 1990; Kaidoh
et al., 1995; Stokkermans et al., 1996; Bogitsh et al., 1999;
Werbovetz et al., 1999; Makioka et al., 2000a,b; Traub-Cseko
et al., 2001; Bhattacharya et al., 2002, 2004; Morrissette and
Sibley, 2002; Werbovetz et al., 2003). Given that the dinitroa-
nilines do not disrupt vertebrate tubulins, dinitroaniline ac-
tivity is of particular interest for the development of new
antiparasitic drugs. We are specifically interested in under-
standing the action of dinitroanilines on apicomplexan par-
asites such as Toxoplasma gondii.
Toxoplasma gondii is a member of the Apicomplexa, a
phylum of protozoa that are obligate intracellular parasites
(Levene, 1988). Parasites released by host cell lysis must
rapidly invade new host cells to stay alive. Despite these
stringent growth requirements, apicomplexans are wide-
spread and damaging pathogens with profound direct and
indirect impacts on human welfare. Human infection by T.
gondii can cause life-threatening illness in immunocompro-
mised individuals and birth defects or miscarriage during
fetal infection (Black and Boothroyd, 2000). Other apicom-
plexans include Plasmodium (agent of malaria) and Crypto-
sporidium (an opportunistic pathogen), which are parasites
of considerable medical importance, and Theileria and Eime-
ria, animal pathogens with extensive impact on food pro-
duction (Levene, 1988).
Apicomplexans are named for their polarized apex that
contains several unique organelles that coordinate invasion
of host cells. Apicomplexan parasites are surrounded by the
pellicle, a composite structure formed by the association of
the plasma membrane with the inner membrane complex,
an assemblage of flattened vesicles. There are two popula-
tions of microtubules in the invasive stages of apicomplexan
parasites: subpellicular microtubules and spindle microtu-
bules (Morrissette and Sibley, 2002). Subpellicular microtu-
bules are nondynamic; they maintain both apical polarity
and the characteristic crescent shape of the parasite by in-
teracting with the pellicle. Spindle microtubules form an
intranuclear spindle to coordinate chromosome segregation.
Both populations are critically important to parasite survival
and replication. Wild-type Toxoplasma parasites are resistant
to 0.2 M oryzalin. This value is difficult to measure
directly, because parasites in oryzalin continue to undergo
protein and DNA synthesis in the absence of microtubule
function, making it impossible to measure IC50 values by
radiolabel incorporation (Stokkermans et al., 1996). Using
drug washout and plaquing values, the approximate IC50
value is 0.1 M oryzalin, and using morphology (round
rather than elongated parasites), parasites begin to round up
by 0.2 M oryzalin (Stokkermans et al., 1996; Morrissette
and Sibley, 2002).
In previous work, we used genetic analysis of oryzalin-
resistant Toxoplasma lines in combination with computa-
tional methods to identify a binding site and mode of action
for the dinitroanilines (Morrissette et al., 2004). Additional
computational analysis extended these studies to include the
interaction of the dinitroanilines oryzalin, trifluralin, and
GB-II-5 with Toxoplasma, Leishmania, Plasmodium, and bovine
tubulins (Mitra and Sept, 2006). The refined dinitroaniline
binding site is located on Toxoplasma, Leishmania, and Plas-
modium -tubulins beneath the N loop, and it is formed by
residues of strand S1 (Arg2, Glu3, Val4, Ile5, Ser6), helix H1
(Cys20, Trp21, Phe24), the N/H1-S2 loop (His28, Met36,
Asp39, Lys40, Thr41, Ile42, Asp47, Pro63, Arg64), strand S2
(Cys65), strand S4 (Leu136), helix H7 (Ile235, Ser236, Thr239,
Ala240, Ser 241), and the T7 loop (Arg243, Phe244, Asp245).
Analysis of vertebrate -tubulin indicates that dinitroanili-
nes have nonspecific, low-affinity interactions and no con-
sensus binding site, consistent with in vivo and in vitro
observations that dinitroanilines do not bind to vertebrate
tubulin or disrupt vertebrate microtubules (Morejohn et al.,
1987; Hugdahl and Morejohn, 1993; Murthy et al., 1994).
When molecular dynamics analysis is used to compare -tu-
bulin mobility in the presence or absence of bound drug,
these simulations suggest that dinitroaniline binding pro-
foundly limits flexibility of the -tubulin N loop, which is
drawn in toward the core of the tubulin dimer (Mitra and
Sept, 2006). We hypothesize that when dinitroanilines bind
tubulin, the N loop is less able to make contacts with the M
loop of the dimer in the adjacent subunit. This prevents
tubulin polymerization, destabilizes preexisting microtu-
bules, or both.
In the work presented here, we have generated Toxoplasma
parasites that bear homologous integrations of many of the
-tubulin point mutations associated with dinitroaniline re-
sistance. We selected the mutations to test in this study by
their predicted mechanism of action: some mutations are
expected to stabilize microtubules (a GTPase-activating do-
main mutant and N and M loop mutants), whereas others
are anticipated to act by altering the dinitroaniline binding
site to lower its affinity for oryzalin. We have characterized
the advantageous features of these mutations (dinitroaniline
resistance) as well as deleterious aspects (increased replica-
tion defects) to conclude that drug resistance has a fitness
cost in T. gondii.
MATERIALS AND METHODS
Culture of Toxoplasma Lines
Toxoplasma tachyzoites (RH strain) were propagated in human foreskin fibro-
blast (HFF) cells in DMEM with 10% fetal bovine serum as described previ-
ously (Roos et al., 1994). Oryzalin (Riedel-deHae¨n, Seelze, Germany) stock
solutions were made up in dimethyl sulfoxide. Oryzalin-resistant parasite
lines were isolated after ethyl-nitrosourea mutagenesis by selection in 0.5 or
2.5 M oryzalin as described previously (Morrissette et al., 2004).
Analysis of 1-Tubulin Point Mutations
The 1-tubulin gene was amplified from genomic DNA isolated from indi-
vidual oryzalin-resistant parasites by using thermal cycling with primers
GAGTCTCGTAGAGAACAAGC (5 untranslated region [UTR]) and CGTT-
TATACCTTCACCTTTTC (3 UTR). The amplified 2.3-kb fragment was se-
quenced and analyzed using Sequencher software (Gene Codes, Ann Arbor,
MI) to identify point mutations in the coding sequence of the 1-tubulin gene.
Primers and methods to sequence the 1-tubulin gene constructs are as
described previously (Morrissette et al., 2004). Similar sequencing analysis
indicated that none of the resistant lines had mutations in the 1-tubulin gene.
We also analyzed the sequences of two recently identified additional Toxo-
plasma -tubulin genes (2-tubulin and 3-tubulin), but we did not identify
any mutations associated with these genes in resistant parasites (data not
shown).
Creation of -Tubulin Point Mutations
The QuikChange kit (Stratagene, La Jolla, CA) was used to modify a previ-
ously generated construct containing a 2.3-kb insert of the Toxoplasma 1-
tubulin gene where a unique XbaI site in the second intron of 1-tubulin was
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replaced with a novel BamHI site. For this study, 21 single point mutations
(Val4Leu, Ser6Ile, Phe24His, His28Gln, Phe49Cys, Phe52Ile, Phe52Leu, Phe52Tyr,
Leu136Phe, Ile235Leu, Ile235Thr, Ile235Val, Arg243Cys, Arg243Ser, Val252Leu,
Met268Thr, Ala273Val, Ile275Thr, Ala295Val, Met301Thr, and Asp367Val) and
two double mutations (Phe52Tyr/Ala273Val and Phe52Tyr/Asp367Val) were
introduced into the Toxoplasma 1-tubulin gene. We also introduced five point
mutations that are observed as differences in the -tubulin genes of Antarctic fish
(Ser187Ala, Ala278Thr, Ser287Thr, Met302Leu, and Met302Phe) into the Toxo-
plasma 1-tubulin gene (Detrich et al., 2000). The mutagenesis primers used to
generate these mutant tubulins are listed in Table 1. All -tubulin constructs were
verified by sequencing as described previously (Morrissette et al., 2004).
Transformation, Selection, and Analysis of
Oryzalin-resistant Transformants
Approximately 107 RH strain tachyzoites were transformed with 8 g of a
linearized construct, selected in 0.5 M oryzalin, and single cell cloned as
described previously (Morrissette et al., 2004). Individual clones were assayed
for homologous integration of the point mutations by amplification of the
1-tubulin gene followed by restriction enzyme analysis of the amplified
insert by using XbaI or BamHI enzymes. Parasites harboring an allelic re-
placement of each point mutation construct were assayed for their drug
resistance using increasing concentrations of oryzalin and scoring for changes
in morphology as described previously (Morrissette et al., 2004). In our
previous study, we isolated and characterized individual clones from a single
transfection and selection of 107 parasites. Because it is possible that these
clones are siblings rather than independent lines, we have altered our ap-
proach during this study to isolate allelic replacements from parasites derived
from more than one independent transfection and selection. Parasites bearing
allelic replacements of the mutations His28Gln, Thr239Ile, Arg243Ser, and
Arg243Cys obtained from two independent transfections and selections
yielded consistent results in this study.
Immunofluorescence of Parasites
Intracellular parasites on 12-mm circular glass coverslips were fixed, perme-
abilized, and stained as described previously (Morrissette and Sibley, 2002).
They were mounted in VECTASHIELD mounting media with 4,6-diamidino-
2-phenylindole (Vector Laboratories, Burlingame, CA). Images of newly in-
vaded parasites stained with a Toxoplasma specific anti--tubulin antibody
(Morrissette and Sibley, 2002) and an Alexa 488 secondary antibody (Invitro-
gen, Carlsbad, CA) were collected on a Zeiss Axioskop using the AxioVision
camera and software (Carl Zeiss, Thornwood, NY). Z-series images were
processed using Zeiss deconvolution software and images were exported and
manipulated in Photoshop 8.0 (Adobe Systems, Mountain View, CA).
Quantification of Replication Defects
Toxoplasma were passed into HFF cells without oryzalin and allowed to grow
until the host cell monolayer was completely lysed. Extracellular wild-type
RH parasites (the parental strain) and parasites bearing homologous integra-
tions of the dinitroaniline resistance mutations were viewed in suspension in
MatTek dishes with a coverslip inset by using a 63 phase-contrast lens on a
Zeiss Axioskop microscope. Images of random fields were captured as tif files
and scored by counting. Three independent samples were counted for each
cell line. In order not to under-represent the aberrant forms, we counted the
number of apical regions to establish total possible parasites lost from the
parasite population through replication defects. All aberrant forms were
counted together.
RESULTS
We have characterized a diverse group of point mutations in
1-tubulin that are associated with oryzalin resistance in T.
gondii (currently 35 different mutations at 25 locations in
1-tubulin). When these mutations are mapped onto a
model of Toxoplasma 1-tubulin, many are located in regions
that suggest that two mechanisms confer resistance in most
cases: mutations that increase dimer–dimer affinity compen-
sate for dinitroaniline disruption of microtubules and mu-
tations that decrease dimer affinity for oryzalin alter the
dinitroaniline binding site (Figure 1). We have used an es-
tablished method to introduce point mutations from these
regions into wild-type Toxoplasma by homologous recombi-
nation (Figure 2A). These 1-tubulin point mutations are
either predicted to increase microtubule stability (mutations
located in the N loop, the M loop, and the GTPase-activating
domain of -tubulin) or to affect the dinitroaniline binding
site (Figure 1). In most cases, the point mutations confer low
levels of oryzalin resistance (0.5–7.5 M). However, four
mutations confer resistance to significantly higher concen-
Table 1. Primers used to introduce tubulin mutations
Mutation Location Primer
Val4Leu Binding site CGACAAAATGAGAGAGCTTATCAGCATCCACGTCGGCCAGGCC
Ser6Ile Binding site CGACAAAATGAGAGAGGTTATCATCATCCACGTCGGCCAGGCCGG
Phe24His Binding site GTTTTCTCTCCTTCTTTTAGGGAGCTCCACTGCCTGGAACATGG
His28Gln N loop/binding site GGAGCTCTTCTGCCTGGAACAAGGTATCCAGCCG
Phe49Cys N loop GGTGGTGACGACGCCTGCAACACCTTCTTTTCCGAGACAGGC
Phe52Ile N loop GACGACGCCTTCAACACCATCTTTTCCGAGACAG
Phe52Leu N loop GACGACGCCTTCAACACCCTCTTTTCCGAGACAG
Phe52Tyr N loop CGACGCCTTCAACACCTACTTTTCCGAGACAGG
Leu136Phe Binding site GCACTGGTCTCCAGGGTTTCTTCATGTTCAACGCCGTCGGC
Ile235Leu Binding site CCTGAACAGACTGATTGCCCAGGTCCTCTCCTCCCTGACCGCG
Ile235Thr Binding site CCTGAACAGACTGATTGCCCAGGTCACCTCCTCCCTGACCGCG
Ile235Val Binding site CCTGAACAGACTGATTGCCCAGGTCGTCTCCTCCCTGACCGCG
Thr239Ile Binding site GCCCAGGTCATCTCCTCCCTGATCGCGTCTCTCCG
Arg243Cys Binding site CGCGTCTCTCTGTTTCGATGGTGCGCTCAACGTCGACG
Arg243Ser Bnding site CGCGTCTCTCAGTTTCGATGGTGCGCTCAACGTCGACG
Val252Leu GAP domain GGTGCGCTCAACGTCGACCTGACTGAGTTCCAGACCAACTTGG
Met268Thr Near M loop CTACCCACGCATTCACTTCACGCTCTCATCGTATGCG
Ala273Val M loop (secondary) GCTCTCATCGTATGTGCCCATCATCAGCGCAGAGAAGG
Ile275Thr M loop CTCATCGTATGCGCCCACCATCAGCGCAGAGAAG
Ala295Val Near M loop CTGAGATCACCAACTCGGTTTTCGAGCCCGC
Met301Thr Near M loop CGAGCCCGCGAGCACGATGGCCAAGTGTGATCC
Asp367Val -Insert (secondary) CCCACTGTGGTTCCTGGTGGTGTCTTGGCCAAGGTCATGCGCGCC
Ser187Ala Fish GCAGTTGTGGAACCGTACAACGCCGTCCTTTCCACTCACTCTCTGTTGG
Ala278Thr Fish, M loop CGTATGCGCCCATCATCAGCACAGAGAAGGCGTACCACGAGCAG
Ser287Thr Fish, M loop GGCGTACCACGAGCAGTTGACTGTCGCTGAGATCACC
Met302Leu Fish, near M loop CGAGCCCGCGAGCATGTTGGCCAAGTGTGATCCTCG
Met302Phe Fish, near M loop CGAGCCCGCGAGCATGTTCGCCAAGTGTGATCCTCG
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trations of oryzalin. Parasites with the Leu136Phe mutation
are resistant to 36 M oryzalin, and those with the Thr239Ile,
Val252Leu, or Arg243Ser mutations are resistant to 40 M
oryzalin (Figure 2B).
In the absence of oryzalin, some of the tubulin mutations
result in Toxoplasma that seem to have a thinner and elongated
shape relative to the dinitroaniline-sensitive parental strain.
This is most obvious in Toxoplasma bearing a homologous
integration of the N loop mutation His28Gln (Figure 3). Three-
dimensional reconstructions of Toxoplasma subpellicular micro-
tubules by using deconvolution microscopy suggest that mi-
crotubule length is increased in parasites with the His28Gln
point mutation (Figure 3, C–E). This increased length is likely
to result from a shift in the equilibrium between tubulin dimers
and microtubule polymers.
To test whether -tubulin amino acid substitutions that are
thought to stabilize microtubules in the Antarctic fish Chiono-
draco rastrospinosus are able to confer resistance to dinitroanili-
nes, we introduced directed changes to Toxoplasma 1-tubulin
to make single point mutations at Ser187Ala, Ala278Thr,
Ser287Thr, Met302Leu, and Met302Phe. Although some of the
Antarctic fish substitutions are very similar to the dinitroani-
line resistance mutations (the oryzalin resistance mutation
Met301Thr is adjacent to the fish mutations Met302Leu and
Met302Phe), we did not recover parasites that had integrated
the altered tubulin after selection in oryzalin. Because we only
select for 1-tubulin gene integrations with dinitroanilines, we
cannot distinguish whether these substitutions do not stabilize
Toxoplasma microtubules to confer resistance or whether the
resulting microtubules are toxic because they are too stable
when expressed in Toxoplasma.
Toxoplasma replicates by endodyogeny, a process of inter-
nal budding. We observed an increased proportion of ab-
normal Toxoplasma “monsters” that are a consequence of
aberrant replication (Figure 4). In many cases, these mon-
sters can be attributed to a failure of mutant parasites to
synchronize nuclear division (which requires spindle micro-
tubules) and the formation of daughter buds (which requires
subpellicular microtubules) during endodyogeny. Toxo-
plasma actively invades host cells by using actin-based mo-
tility in conjunction with a moving junction that forms be-
tween the parasite and the host plasma membrane (Soldati
and Meissner, 2004). Parasites that lack a rigid elongated
crescent shape are incapable of invading host cells (Stokker-
mans et al., 1996; Shaw et al., 2000; Morrissette and Sibley,
2002; Morrissette et al., 2004). Because abnormal forms that
fail to complete scission (examples 4–11 in Figure 4C) cannot
invade new host cells, these are nonviable organisms. There
may also be other defective parasites that have lost single
chromosomes but seem normal at the level of the light
microscope. We attempted to evaluate the frequency of
chromosome missegregation using flow cytometry of intra-
cellular (released by syringe passage) parasites stained with
SYTOX-green. Toxoplasma has 14 chromosomes; therefore,
the loss of a single chromosome would be associated with an
7% decrease in staining intensity for a small subpopulation
of parasites associated with the 1N peak. We were not able
to resolve any reproducible differences in DNA content
Figure 1. A model of the structure of Toxo-
plasma 1-tubulin with bound oryzalin (or-
ange) based on previous molecular dynamics
and docking results (Morrissette et al., 2004).
Binding site residues that occur as point mu-
tants are colored green. The N and M loops are
colored mauve and the GTPase-activating do-
main is highlighted in yellow. (A) The N loop
residues His28, Phe49, and Phe52 are mutated
in dinitroaniline-resistant Toxoplasma lines. (B)
The M loop contains Ala273 and Ile275, which
are identified in dinitroaniline resistant -tu-
bulin genes and other mutations at Met268,
Ala295, and Met301 are nearby the M loop.
The Ala273 mutation is a second site mutation
rather than a resistance mutation (see below).
(C) The GTPase activating domain of -tubu-
lin (yellow) contains a resistance mutation at
Val252. Residues Asp251 and Glu254 (aster-
isks) were shown previously to be essential
residues for activating the GTPase of -tubu-
lin (Anders and Botstein, 2001). (D) The dini-
troaniline binding site is defined by several
residues, including 11 that are mutated in re-
sistant parasites. These residues are Val4, Ser6,
Phe24, His28 (also in the N loop), Leu136,
Ile235, Thr239, and Arg243. (E) The entire
-tubulin subunit is displayed with the adja-
cent - heterodimer contact area in the fore-
ground. The -tubulin subunit of the het-
erodimer (data not shown) would be behind
the -tubulin structure.
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given the variation associated with this assay and the reso-
lution required for this measurement (data not shown). We
demonstrated previously that anucleate Toxoplasma (exam-
ple 2 in Figure 4C) can invade host cells, but obviously
cannot proliferate in the absence of a nuclear genome (Mor-
rissette and Sibley, 2002). Similarly, parasites with inappro-
priate chromosome content may seem normal and reinvade
host cells, but they will be unable to grow and replicate.
When the relative occurrence of grossly abnormal extra-
cellular parasites is quantified for the parental Toxoplasma
strain and parasite lines bearing homologous integrations of
the 1-tubulin point mutations, it is clear that all of the point
mutations are associated with some degree of increased
rates of replication defects (Figure 5). Extracellular RH (pa-
rental strain) Toxoplasma have 4% of parasites with overt
replication defects. Enhanced replication defect rates are
particularly obvious in N loop mutants, which have 10–13%
of extracellular parasites that are grossly altered and inca-
pable of continued cycles of invasion and replication. The
binding site mutation Arg243Ser has high oryzalin resis-
tance (41 M) tempered by an 12% rate of replication
defects.
Parasites bearing the N loop mutation Phe52Tyr have
resistance to 7 M oryzalin. When this strain was grown in
the absence of oryzalin, it spontaneously acquired second
site mutations at Ala273Val or Asp367Val. Our gene replace-
ment method is limited to introducing 1-tubulin transgenes
that can be selected for by oryzalin resistance. Despite sev-
eral attempts to isolate parasite lines bearing Ala273Val and
Asp367Val as single mutations to the 1-tubulin gene, we
were unable to obtain them, suggesting that they do not
confer resistance. When combined with Phe52Tyr, the
Ala273Val and Asp367Val mutations were easily isolated as
homologous integrations, and parasite lines with the double
mutations (Phe52Tyr/Ala273Val and Phe52Tyr/Asp367Val)
showed lower resistance than that of parasites with
Phe52Tyr mutation alone. We have, therefore, concluded
that the Ala273Val and Asp367Val mutations do not confer
oryzalin resistance alone, and when combined with the
Phe52Tyr mutation, the second site mutations decrease re-
sistance to 2.8 and 3.3 M oryzalin, respectively (Figure 6A).
The degree of replication defects in the single mutation
Phe52Tyr (13%) is higher than that of the double muta-
tions (6 and 5%), suggesting that in the absence of oryza-
lin, replication defects are sufficiently deleterious to select
for spontaneous secondary mutations that correct this dis-
advantageous condition (Figure 6B). The location of the
second site mutations is consistent with a role in decreased
protofilament interactions. The Ala273Val mutation is in the
M loop and the Asp367Val mutation is in an -tubulin insert
that stabilizes the -tubulin M loop. The substitution of Val
for Asp at this location disrupts a salt bridge between
Asp367 and Arg229, presumably destabilizing the insert,
which in turn destabilizes the M loop protofilament contact
(Figure 6C).
DISCUSSION
Dinitroaniline resistance mutations have been reported in
the unicellular green alga Chlamydomonas reinhardtii, in
higher plants such as Eleusine indica (goosegrass) and Setaria
viridis (green foxtail), and in the protozoans T. gondii and
Tetrahymena thermophila (Schibler and Huang, 1991; James et
al., 1993; Gaertig et al., 1994; Anthony et al., 1998; Yamamoto
et al., 1998; Delye et al., 2004). In some cases, such as
Thr239Ile and Leu136Phe, the same -tubulin mutation has
been identified in dinitroaniline-resistant Toxoplasma, Eleus-
Figure 2. (A) Diagram of the exon–intron
structure of 1-tubulin used for the allelic re-
placement strategy. Endogenous (wild-type)
1-tubulin has a unique XbaI restriction site in
intron 2. The transgene was altered to ablate
the XbaI site and to introduce a unique BamHI
site in intron 2. The individual point muta-
tions were introduced in the transgene con-
struct and electroporated into Toxoplasma. Par-
asites with a homologous integration of the
transgene are identified by conversion of the
XbaI restriction site to a BamHI site. (B)
Oryzalin resistance of Toxoplasma with allelic
integration of the 1-tubulin gene containing
the individual point mutations in the binding
site (BS), N loop (NL), M loop (ML), and GTPase-
activating domain (GD). Resistance conferred
by the predicted binding site mutation
Thr239Ile was previously reported to be 5 M,
which is in error. We have generated two new
independent integrations of the Thr239Ile con-
struct that have resistance to 41 M oryzalin,
as illustrated here.
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ine, and Setaria. In data presented here, we demonstrate that
resistance mutations identified in other species function to
confer resistance in Toxoplasma. The Met268Thr mutation
observed in Eleusine confers dinitroaniline resistance in Tox-
oplasma as does a Phe24His substitution that is analogous to
the Tyr24His mutation in Chlamydomonas (James et al., 1993;
Anthony et al., 1998; Yamamoto et al., 1998). However, when
we attempted to introduce substitutions that are hypothe-
sized to confer cold stability to the microtubules of Antarctic
fish (Detrich et al., 2000), they do not confer oryzalin resis-
tance. Because we select for transformation with dinitroani-
lines, we are unable to distinguish whether these substitu-
tions do not confer dinitroaniline resistance in Toxoplasma or
whether they are lethal when expressed because the micro-
tubules are too stable.
The observations presented in this article 1) that M and N
loop mutations have relatively low resistance and the high-
est incidence of replication defects and 2) that a subset of
binding site mutations have extremely high resistance are
consistent with our working model that invokes two major
mechanisms of dinitroaniline resistance. In this study, we
selected a subset of tubulin mutations to analyze from a
larger collection of substitutions conferring dinitroaniline
resistance based on the location of the altered residues in the
structure of -tubulin. In previous work, we characterized
homologous integrations of five resistance mutations that
were selected from the larger set of mutations. Three of the
previously studied mutations were distinct substitutions
(Ala, Pro, Thr) to Ser165: these mutations conferred rela-
tively low dinitroaniline resistance (1–2 M oryzalin). Other
researchers subsequently identified Ser165Pro as an -tubu-
lin mutation associated with resistance to HTI-286 (a hemi-
asterlin derivative) in human carcinoma cell lines (Poruchynsky et
al., 2004). Because the hemiasterlin binding site has been
located in a distinct region of the tubulin dimer at the
--subunit interface, predominantly in -tubulin, we ex-
pect that the Ser165Pro mutation is associated with general
microtubule stability (Mitra and Sept, 2004; Ravi et al., 2005).
The other two previously studied point mutations were
Thr239Ile, which had been previously identified in dinitroa-
niline-resistant goosegrass and Ile231Thr, which is in the
same face of -helix 7 as Thr239 (Morrissette et al., 2004). The
original Thr239Ile line did not survive freezing and we
recently discovered that in two new and independent inte-
grations, the Thr239Ile confers resistance to 40 M oryzalin
(Figure 2). This suggests that the previous line was an in-
correctly genotyped nonhomologous integration. Our cor-
rected observation is consistent with the other data pre-
sented here that suggests that mutations to residues in the
binding site are associated with high resistance (Figure 2).
Previous researchers have demonstrated the importance
of the M and N loop residues in microtubule function and
stability by using both natural mutations and directed sub-
stitutions to these domains in -tubulin. Alanine scanning
studies in budding yeast have identified -tubulin N loop
mutations that are benomyl resistant, presumably due to
increased microtubule stability, or benomyl supersensitive,
presumably due to decreased microtubule stability (Richards et
al., 2000). Alanine scanning analysis also indicates that M
loop substitutions are associated with benomyl supersensi-
tivity, revealing that these microtubules have decreased sta-
bility (Richards et al., 2000). The -tubulin N loop mutation
Glu55Lys and the M loop mutation His283Tyr confer colci-
mid and vinblastine resistance in human cells (Hari et al.,
2003).
Dynamic instability of microtubules depends on the po-
lymerization-stimulated hydrolysis of GTP bound to -tu-
bulin, and it is necessary for microtubule disassembly (Davis
et al., 1994; Sage et al., 1995; Anders and Botstein, 2001;
Dougherty et al., 2001). Experiments in budding yeast indi-
cate that two residues (Asp252 and Glu255) in -tubulin
activate the -tubulin GTPase in the adjacent dimer (Richards et
al., 2000; Anders and Botstein, 2001). When these residues
are mutated to alanine, the resulting dimers are poisonous
and are lethal as a minor component of the total tubulin
population (Anders and Botstein, 2001). Budding yeast with
induced expression of mutant -tubulins (Asp252Ala,
Glu255Ala, and Asp252Ala/Glu255Ala) have aberrant bun-
dled microtubules. These microtubules are not dynamic, and
microtubule-disrupting drugs are incapable of disrupting
the microtubules. The dinitroaniline-resistance mutation in
Toxoplasma 1-tubulin at Val252Leu is not the equivalent
residue to the Asp252 residue in Saccharomyces cerevisiae. The
Toxoplasma Val252 residue is equivalent to Leu253 in yeast,
and so it is immediately adjacent to the critically important
residue (Figure 1C). We hypothesize that the Val252Leu
mutation may decrease the activity of the GTPase-activating
domain to increase microtubule stability. This mutation is
associated with very high dinitroaniline resistance, but it
does not seem to cause the parasites to have obviously
longer and more stable microtubules.
Our analysis of the effect of tubulin mutations on replica-
tion indicates that all of the resistance mutations confer
increased rates of defects to negatively influence parasite
Figure 3. Phase-contrast microscopy of extracellular wild-type (A)
and His28Gln mutant parasites (B) illustrates that Toxoplasma ex-
pressing the His28Gln mutation are thinner and longer and they
show an increased frequency of septation defects. (C–E) Projections
of wild-type (C) and His28Gln mutant parasites (E) indicate that
His28Gln mutant parasites have longer microtubules. These three-
dimensional projections were created by collecting Z-series images
of newly invaded parasites stained with a Toxoplasma-specific tubu-
lin antibody. The images were processed with Zeiss deconvolution
software. An overlay of the wild-type parasite projection (green)
on the His28Gln mutant parasite projection (red) illustrates the
increased subpellicular microtubule length in the mutant para-
sites (D).
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fitness. As shown in Figure 5, substitutions predicted to
hyperstabilize microtubules (M and N loops) are generally
associated with the highest rates of replication defects. This
may be associated with defective chromosome segregation,
because previous studies have associated decreased micro-
tubule dynamics with chromosome loss (Beinhauer et al.,
Figure 4. Hyperstabilized microtubules af-
fect the fidelity of parasite replication (A) Tox-
oplasma parasites replicate by endodyogeny, a
process of internal budding that creates two
internal daughter parasites within a mother
parasite. This process permits an apically po-
larized “mother” parasite to undergo mitosis
while building two polarized daughter buds,
each consisting of inner membrane complex,
subpellicular microtubules, and apical or-
ganelles around the daughter nuclei. When
the daughter parasites are mature, they
emerge from the mother, adopting her
plasma membrane. (B) Illustration of the ab-
errant forms of extracellular parasites: (i)
anucleate and (ii) diploid parasites result
from completion of cytokinesis in the absence
of nuclear division; (iii) parasites that com-
plete cytokinesis in the absence of nuclear
division can exclude nuclear material; two-
headed (iv) or multiple headed (v) parasites
result from arrest during cytokinesis in the
absence of nuclear division; (vi) and parasites
with late completion of nuclear division can
fail to complete septation (cytokinesis). (C)
Phase-contrast images of malformed extracel-
lular parasites. The large panel shows an ap-
parently wild-type parasite (1) next to an
anucleate parasite (2) and a grossly enlarged
parasite (3). The anucleate and enlarged par-
asites (2 and 3) likely result from cytokinesis without nuclear division as illustrated in B iv, which shows similar parasites jointed by incomplete
cytokinesis. Incomplete septation of one (5), two (6), three (7), or four (8 and 9) daughter buds from a residual body containing some or all nuclear
material. Parasites in 10 and 11 have completed nuclear division and daughter cell formation, but they have not completed septation.
Figure 5. Quantification of gross replication defects in the individual -tubulin lines. Relative proportion of replication defects in wild-type
parasites and the individual homologous integrations. The parental RH strain has 4% aberrant extracellular parasites. The binding site (BS),
N loop (NL), M loop (ML) and GTPase-activating domain (GD) mutants all have some degree of increased replication defects.
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1997; Asakawa et al., 2006). Because we do not think that the
putative binding site mutations influence microtubule sta-
bility, we hypothesize that they alter some other aspect of
tubulin function, such as tubulin folding or subunit flexibil-
ity, in Toxoplasma. In budding yeast, alanine scanning mu-
tations in tubulin have been shown to alter folding or other
aspects of subunit function to influence drug resistance or
hypersensitivity and microtubule sensitivity to heat or cold.
For example, altering residues of the GTP binding domain of
-tubulin (such as the triple mutation Lys97Ala/Glu98Ala/
Asp99Ala) confers cold sensitivity and benomyl supersensitiv-
ity, perhaps as a consequence of altered tubulin folding (Richards
et al., 2000). In contrast, several mutations in yeast -tubulin
(Glu108Ala/Glu111Ala, Glu123Ala, and Arg282Ala/Glu288Ala)
are cold sensitive but benomyl resistant (Reijo et al., 1994).
Ultimately, the significant issue is whether resistant par-
asites could be sufficiently fit to be spread throughout
natural populations in competition with wild-type para-
sites in the absence of drug selection. This might be
achieved by high resistance due to multiple mutations or
through multiple mutations that confer resistance but
maintain fitness.
Toxoplasma parasites bearing the N loop mutation
Phe52Tyr have resistance to 7 M oryzalin, but 13% of the
parasite population has overt replication defects, possibly
due to microtubules with increased stability. When this par-
asite strain was grown in the absence of oryzalin, it sponta-
neously acquired secondary mutations in the M loop
(Ala273Val) or in an -tubulin-specific insert that stabilizes
the M loop (Asp367Val). The Asp367Val point mutation
eliminates a salt bridge between Asp367 and Arg229. This
salt bridge stabilizes the -tubulin insert, and in turn, the
insert stabilizes the -tubulin M loop (Figure 6C). We expect
that elimination of the salt bridge ultimately decreases the
strength of the -tubulin M loop contact within the proto-
filament, akin to the action of the Ala273Val mutation, which
is directly in the M loop. We hypothesize that the secondary
mutations increase Toxoplasma fitness by decreasing micro-
tubule stability. Consistent with this hypothesis, parasites
with the double mutations have both decreased dinitroani-
line resistance and decreased incidence of replication de-
fects. It is likely that the Phe52Tyr strain has a high rate of
chromosome segregation defects that provide a strong se-
lective pressure for second site mutations to correct for
tubulin function in the absence of dinitroaniline selection.
Previous work in the fission yeast Schizosaccharomyces pombe
has indicated that tubulin mutations (the -tubulin mutation
Val260Ile) or the loss of the EB-1 homologue MAL3 are
associated with less dynamic microtubules and increased
rates of chromosome loss (Beinhauer et al., 1997; Asakawa et
al., 2006).
Collectively, the results presented in this article suggest
that mutations to 1-tubulin confer dinitroaniline resistance
at a cost to microtubule function and parasite fitness. Since a
number of novel mutations confer resistance, it is important
to evaluate whether parasites treated with microtubule-dis-
rupting drugs would rapidly acquire resistance mutations if used
in a therapeutic setting. Studies that have exploited growth
competition assays to assess the fitness of Toxoplasma strains
bearing wild-type or pyrimethamine-resistant dihydrofolate
reductase genes have concluded that even strains that be-
have identically in vitro can display growth defects in vivo
(Fohl and Roos, 2003). Our dinitroaniline-resistant strains
have overt replication defects in vitro, suggesting that they
have reduced fitness and would fare poorly in similar com-
petition assays. Therefore, drugs that selectively target par-
asite microtubules remain a compelling option for the de-
velopment of new antiparasitic therapies.
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Figure 6. Dinitroaniline resistance is sufficiently deleterious that in the absence of oryzalin selection, Toxoplasma parasites harboring the
Phe52Tyr mutation acquire compensatory second site mutations at either Ala273Val (the M loop) or Asp367Val. (A) Oryzalin resistance of
the single mutant Phe52Tyr (7 M) is greater than that of the double mutants Phe52Tyr/Ala273Val (2.8 M) and Phe52Tyr/Asp367Val (3.3
M). The single substitutions Ala273Val or Asp367Val do not confer any oryzalin resistance. (B) Replication defects associated with the single
mutant Phe52Tyr are greater (13%) than those in the double mutants Phe52Tyr/Ala273Val (6%) and Phe52Tyr/Asp367Val (5%). (C)
Substitution of Val for Asp at residue 367 disrupts a salt bridge that links Arg229 (blue) to Asp367 (red) within the -tubulin–specific insert
(green). The eight amino acids of the insert stabilize the M loop (purple) of -tubulin.
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